Genmab AS (GMAB)

Genmab AS (GMAB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $26.9B; returns 1 day +9.5%, 1 week +18.4%, 1 year +46.6%.

Genmab A/S is a leading international biotechnology company headquartered in Denmark, dedicated to creating and developing innovative antibody-based therapeutics for cancer and other serious diseases.

Groups GMAB belongs to

• Biotechnology
• Oncology
• Antibody Therapeutics
• Healthcare
• Life Sciences
• Biopharmaceutical
• Bispecific Antibodies
• Commercial Stage Biotech
• Royalty Streams
• Monoclonal Antibodies
• Cancer Therapeutics
• Hematologic Malignancies
• R&D

GMAB financial model: income statement, cash flow and balance sheet